Sionna Therapeutics, Inc. · NASDAQ:SION

Orbimed Advisors LLC reported a 6.60% stake in Sionna Therapeutics, Inc. (Schedule 13D/A)

Event Apr 15, 2026 · Filed Apr 20, 2026

Orbimed Advisors LLC reported a 6.60% stake in Sionna Therapeutics, Inc., 2,967,722 shares, with active intent on Apr 15, 2026. Filed Apr 20, 2026 (Schedule 13D/A).

Stake
6.60%
Shares
2,967,722
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC6.60%2,967,722
OrbiMed Capital GP VIII LLC6.60%2,967,722

Source

View original at SEC

Related